New Cystic Fibrosis Therapy Seeks Refund Approval in Poland

Vertex Pharmaceuticals has applied for refund approval for its latest drug, a new targeted therapy for specific genetic subtypes of cystic fibrosis, in Poland. The company continues to seek therapies for the condition.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

rzeczpospolitaPolish158d ago

Nowa terapia dla chorych na mukowiscydozę

Nieustannie poszukujemy terapii ukierunkowanych na konkretne podtypy genetyczne mukowiscydozy. Złożyliśmy wniosek o objęcie refundacją naszego najnowszego leku – mówi Marek Macyszyn dyrektor generalny Vertex Pharmaceuticals Polska i Czechy.

Read full article →

New Cystic Fibrosis Therapy Seeks Refund Approval in Poland

Sources

Nowa terapia dla chorych na mukowiscydozę

Related Stories

Severe Algae Bloom Threatens Israel’s Desalination Infrastructure and Water Supply

Ig Nobel Prizes Awarded at First Ceremony Held Outside the United States

Dutch Soil Scientist Wins Ig Nobel Prize for Underwear Burial Experiment

Quirky Research on Urinals and Candy Stealing Wins Ig Nobel Prizes